WELCOME TO OUR NEW WEBSITE! -- LEARN MORE

Welcome to our new site!

We have updated our website to make it easier for you to place and track orders, refill your prescriptions, and view your account information. If you are already a customer, you will now be able to access your account directly. We have also enhanced our security to ensure the protection of your information.

IF YOU ARE ALREADY A CUSTOMER:
You will soon receive an email with a Username and Password that you can use to log in to your account. Be sure to check your spam folder for this email. If you do not receive this email, or if you have trouble logging into your account, please contact us toll-free at 1-844-560-7790.

IF YOU ARE A NEW CUSTOMER:
You can easily register a free account by clicking here. If you have any trouble, please call us at 1-844-560-7790.

We apologize for any inconvenience or issues you may experience as we continue adjusting our new website. We hope you will enjoy our updates and continue saving on your brand insulin!

Learn how to order on our new site by clicking here.

Contact us
Customer Service Hours
Mon-Fri 9AM to 6:30PM EST
Email service@canadianinsulin.com
Phone 1-844-560-7790
Fax 1-866-951-0118

Recent Articles

Follow Us

Buy Glyxambi Online From Canada

What is Glyxambi?

Glyxambi is a diabetes medicine that contains both linagliptin and empagliflozin as the active ingredients. Linagliptin belongs to a class of medications called dipeptidyl peptidase-4 (DPP-4) enzyme inhibitors, whereas empagliflozin is a type of sodium-glucose co-transporter (SGLT2) inhibitor. Each Glyxambi tablet contains 5mg of linagliptin and 10mg or 25mg empagliflozin. Glyxambi is a product of Boehringer Ingelheim, a global pharmaceutical company based in Germany.

What is it used for?  

Containing both linagliptin and empagliflozin, Glyxambi is prescribed as an adjunctive therapy to improve blood glucose control in diabetic patients. For best results, Glyxambi should be used in combination with lifestyle modifications such as exercise and dietary change. Conventionally, empagliflozin is indicated for reducing the risks of cardiovascular death in adult patients with a comorbidity of cardiovascular disease and type II diabetes mellitus. Glyxambi is not intended for use in patients who have diabetic ketoacidosis or type I diabetes.

How to take this medication

Take the drug once daily in the morning. Glyxambi can be taken with or without food. While taking Glyxambi, patients should follow all the recommendations by doctors (e.g. exercise or dietary change) for optimal treatment outcomes. If patients miss a dose of Glyxambi, they should take the missed dose as soon as it is remembered. However, if it is almost time for the next dose, they should skip the missed dose and take the next dose as scheduled. Patients should not double up on the dose under any circumstances. Glyxambi can be used along with other anti-hyperglycemic agents; however, there is a higher risk of hypoglycemia (low blood glucose) when Glyxambi is used concomitantly with other diabetes medications.

How does this drug work?

The active ingredients of Glyxambi (empagliflozin and linagliptin) work synergistically to enhance glycemic control in diabetes patients. As previously mentioned, empagliflozin is an inhibitor of the sodium-glucose co-transporter (SGLT2) while linagliptin is known to inhibit dipeptidyl peptidase-4 (DPP-4) enzymes. Sodium-glucose co-transporter 2 is the main transporter that reabsorbs glucose from the glomerular filtrate. Through its inhibitory actions on SGLT2, empagliflozin decreases the renal reabsorption of filtered glucose, thereby lowering the renal threshold for glucose and increasing the urinary excretion of glucose. Linagliptin, on the other hand, has inhibitory actions on dipeptidyl peptidase-4. DPP-4 is an enzyme responsible for the degradation of the glucose-dependent insulinotropic polypeptide (GIP) and incretin hormones glucagon-like peptide-1 (GLP-1). Linagliptin helps increase the concentration of active incretin hormones while promoting the insulin release in a glucose-dependent manner. at the same time, it decreases the level of glucagon in the blood circulation.

Dosage

The recommended daily dose of Glyxambi (empagliflozin/linagliptin) is 10mg/5mg. If well tolerated, the dose of Glyxambi can be further increased to 25mg/5mg.

Side effects

  • Runny nose
  • Stuffy nose
  • Upper respiratory tract infections
  • Sore throat

Please note that this section does not contain all the potential side effects of Glyxambi. Adverse effects other than the ones in this list may occur in some patients. If symptoms persist or worsen, patients should see a doctor without delay. If there is any serious side effect, patients should seek medical attention right away.

Can't find what you're looking for?

Give us a call at 1-844-560-7790 or email us at service@canadianinsulin.com

Reset Your Password

Please enter your Username below and we will send a new password to the email associated with your account. Check your spam folder if you do not receive your new password.

Still having trouble logging in?

If you’re unable to log in, please call our customer service at 1-844-560-7790.